93 related articles for article (PubMed ID: 27809679)
1. Induction of Both Local Immune Response in Mice and Protection in a Rabbit Model by Intranasal Immunization with Modified Vaccinia Ankara Virus Expressing a Secreted Form of Bovine Herpesvirus 1 Glycoprotein D.
Del Medico Zajac MP; Zanetti FA; Esusy MS; Federico CR; Zabal O; Valera AR; Calamante G
Viral Immunol; 2017; 30(1):70-76. PubMed ID: 27809679
[TBL] [Abstract][Full Text] [Related]
2. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models.
Ferrer MF; Del Médico Zajac MP; Zanetti FA; Valera AR; Zabal O; Calamante G
Viral Immunol; 2011 Aug; 24(4):331-9. PubMed ID: 21830904
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
4. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
[TBL] [Abstract][Full Text] [Related]
5. A chimeric baculovirus displaying bovine herpesvirus-1 (BHV-1) glycoprotein D on its surface and their immunological properties.
Peralta A; Molinari P; Conte-Grand D; Calamante G; Taboga O
Appl Microbiol Biotechnol; 2007 May; 75(2):407-14. PubMed ID: 17285288
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.
Gogev S; Vanderheijden N; Lemaire M; Schynts F; D'Offay J; Deprez I; Adam M; Eloit M; Thiry E
Vaccine; 2002 Jan; 20(9-10):1451-65. PubMed ID: 11818166
[TBL] [Abstract][Full Text] [Related]
7. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle.
Huang Y; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2005 Apr; 86(Pt 4):887-898. PubMed ID: 15784883
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a needle-free delivery platform for prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus 2 glycoprotein D.
Meseda CA; Stout RR; Weir JP
Viral Immunol; 2006; 19(2):250-9. PubMed ID: 16817767
[TBL] [Abstract][Full Text] [Related]
9. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a bovine herpes virus I peptide expressed in tandem copies in attenuated Salmonella.
Gnazzo V; Cebrian I; Langellotti C; Chabalgoity J; Mongini C; Quattrocchi V; Zamorano P
Viral Immunol; 2012 Feb; 25(1):63-72. PubMed ID: 22233252
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
[TBL] [Abstract][Full Text] [Related]
13. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle.
Reddy PS; Idamakanti N; Pyne C; Zakhartchouk AN; Godson DL; Papp Z; Baca-Estrada ME; Babiuk LA; Mutwiri GK; Tikoo SK
Vet Immunol Immunopathol; 2000 Oct; 76(3-4):257-68. PubMed ID: 11044558
[TBL] [Abstract][Full Text] [Related]
15. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
[TBL] [Abstract][Full Text] [Related]
16. Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.
Zheng C; Babiuk LA; van Drunen Littel-van den Hurk S
J Virol; 2005 Feb; 79(3):1948-53. PubMed ID: 15650221
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3.
Mackenzie-Dyck S; Latimer L; Atanley E; Kovacs-Nolan J; Attah-Poku S; Babiuk LA; van Drunen Littel-van den Hurk S
Clin Vaccine Immunol; 2015 Jan; 22(1):79-90. PubMed ID: 25378352
[TBL] [Abstract][Full Text] [Related]
18. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
Kingstad-Bakke B; Kamlangdee A; Osorio JE
Vaccine; 2015 Sep; 33(39):5155-62. PubMed ID: 26271828
[TBL] [Abstract][Full Text] [Related]
19. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27.
Bright H; Perez DL; Christy C; Cockle P; Eyles JE; Hammond D; Khodai T; Lang S; West K; Loudon PT
Vaccine; 2012 Dec; 30(52):7529-35. PubMed ID: 23103198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]